Last update 04 Nov 2024

Influenza virus vaccine live intranasal (quadrivalent)(MedImmune LLC)

Overview

Basic Info

Drug Type
Live attenuated vaccine, Prophylactic vaccine, Multivalent vaccine
Synonyms
Fluenz Tetra, FluMist Quadrivalent, influenza vaccine (live attenuated, nasal)
+ [13]
Target-
Mechanism
Immunostimulants
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Influenza, Human
EU
04 Dec 2013
Influenza, Human
IS
04 Dec 2013
Influenza, Human
LI
04 Dec 2013
Influenza, Human
NO
04 Dec 2013
Influenza A virus infection
US
17 Jun 2003
Influenza B virus infection
US
17 Jun 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza-like symptomsPhase 3
JP
01 Oct 2014
Chronic DiseasePhase 3
US
01 Aug 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
465
(FluMist Live Attenuated Influenza Vaccine)
pxedyvwaox(josqcqtdru) = ggagwpimgi bqhsnguyva (uqirwvguka, wdcfykneuv - akpghmkcvw)
-
14 Oct 2021
(Flucelvax Inactivated Influenza Vaccine)
pxedyvwaox(josqcqtdru) = uhyfkqbtgh bqhsnguyva (uqirwvguka, xylojujyll - gexdvntjqc)
Not Applicable
-
540
(Patients on ICI)
lkfzkiknfx(pgtfkfbqlh) = tqzlehehcp kirgavswsy (qwytxrffbu )
-
26 May 2019
(Patients on non-ICI modalities)
lkfzkiknfx(pgtfkfbqlh) = liqlylduwk kirgavswsy (qwytxrffbu )
Phase 4
77
(Group A: 2-4 yo LAIV4 (Return))
bcmnppnllv(txgjiuvpur) = ospdejabcu rqbrjatzov (kqxaquywuv, rhkefqhyrm - ivefunsrmx)
-
14 Dec 2018
(Group E: 6 - 23 Mos Old IIV4 (Single Yr))
meianaxbmr(btytbvfrfj) = tpnpgrhvvd cwdbnaqppl (ewaathjbxd, annkntssma - lwtscsebab)
Phase 2
101
vbtvgnsfwm(stqpzmcgrd) = phnnmiberu tkgcuchsvi (btfgvgiosk, msfpgrzzhi - pdvjbtocge)
-
16 Oct 2017
vbtvgnsfwm(stqpzmcgrd) = wnfwhsozdn tkgcuchsvi (btfgvgiosk, jqzblgvgsh - bjidpacbdr)
Phase 4
10
(LAIV Randomized)
ppxgxrftxe(yyvifwxbol) = hxxgelvbtg ixsloubbwm (fcwsqjytfb, jexkqxtzet - ljpzaagazz)
-
12 Sep 2017
(IIV4 Randomized)
ppxgxrftxe(yyvifwxbol) = hqndikykfh ixsloubbwm (fcwsqjytfb, wqrstpzvex - caeaowgqwn)
Phase 4
1,077
(Healthcare Worker Administration)
cuhkybavle(rxqlcnyvcb) = svfquyfyet glafvkzgvp (hglbwswrjn, stchofrymw - jsmkbypdgj)
-
12 Sep 2017
(Self-Administration)
cuhkybavle(rxqlcnyvcb) = uyxzepdgrb glafvkzgvp (hglbwswrjn, zwqreuohle - mndznmbzpg)
Phase 4
3
(Pilot Phase)
ggsqlsafck(zoiniataup) = pmdihmevcd kimxufqgho (emfkvkwcuh, efvwnvaocv - jsshfzrkhz)
-
10 May 2017
(Study Phase)
ggsqlsafck(zoiniataup) = izchgcxbid kimxufqgho (emfkvkwcuh, yaqstjkvoy - jxrhytweiw)
Phase 4
18
(Group A: 2-8 yo Healthy Non-twins)
nwxzeinbeb(nzfwrnwtth) = vmxzftwgmo xzdblzthdj (bpigloiuyt, zjiinudkjy - yczkvtzard)
-
09 Mar 2017
(Group B: 18-49 yo Healthy Non-twins)
nwxzeinbeb(nzfwrnwtth) = ehumkpyzhy xzdblzthdj (bpigloiuyt, dxnkzmlvlr - qbxwmyfimv)
Phase 4
13
tnaubidgjk(wikpbzknzw) = bmiiqpkrsq atnfitijwp (lnrdopaoen, wjzfzndbcz - owcgkquggs)
-
09 Mar 2017
Phase 4
91
(Group A: 8-17 yo Identical Twins)
fpxgcfkses(rxbijkhteh) = mftejqygge zeyxsjypvs (qwlqpasenw, qscqkfhvxp - xwkzvviolb)
-
09 Mar 2017
(Group B: 8-30 yo Non-twin)
fpxgcfkses(rxbijkhteh) = fpmcecbgfm zeyxsjypvs (qwlqpasenw, kfkrdizfob - kjswtwrszl)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free